Erectile dysfunction (ED) significantly impacts quality of life. While inflatable penile prosthesis (PP) implantation is the gold standard for treatment-refractory cases, assessing long-term patient satisfaction remains a challenge due to the subjective nature of outcomes. This study aimed to evaluate long-term satisfaction following IPP implantation using the validated French version of the Satisfaction Survey for Inflatable Penile Implant (SSIPI), while assessing perioperative outcomes and long-term device survival.
This retrospective single-center study included all consecutive patients who underwent IPP implantation during 10 years. Patient satisfaction was assessed via telephone interviews using the SSIPI questionnaire. Revision-free and removal-free survival were analyzed. Complications were classified according to the EAU Intraoperative Adverse Incident and Clavien-Dindo classifications.
A total of 201 patients were included (median age 63.3 years). Among them, 89 (44.3%) completed the SSIPI questionnaire. The median SSIPI score was 67 [59-73], with 88.7% of patients classified as satisfied and 58.4% as highly satisfied. No significant predictors of satisfaction were identified. The overall postoperative complication rate was 16.9%, with 3% requiring surgical revision within 30 days. During follow-up, 30.3% of patients underwent surgical revision, including 10.9% device removal. Revision-free survival at 60 months was 61.7%, and device survival without removal was 83.6%. A history of prior PP implantation was the only significant risk factor for revision and removal.
IPP implantation provides high patient satisfaction. Outcomes are multifactorial and cannot be explained solely by surgical success. Identifying predictors of dissatisfaction is essential to optimize long-term patient management.
The French journal of urology. 2026 Jun 25 [Epub ahead of print]
Pauline Neuranter, Jeanne Beirnaert, Morgan Roupret, Ugo Pinar
Sorbonne Université, GRC 5 Prédictive Onco-Uro, AP-HP, Urologie, Hôpital Pitié-Salpêtrière, F-75013 Paris, France., Sorbonne Université, GRC 5 Prédictive Onco-Uro, AP-HP, Urologie, Hôpital Pitié-Salpêtrière, F-75013 Paris, France; Université Libre de Bruxelles, Hôpital Erasme, Service d'Urologie, 1080 Bruxelles, Belgium., Sorbonne Université, GRC 5 Prédictive Onco-Uro, AP-HP, Urologie, Hôpital Pitié-Salpêtrière, F-75013 Paris, France; Université Libre de Bruxelles, Hôpital Erasme, Service d'Urologie, 1080 Bruxelles, Belgium. Electronic address: .